IDiyas

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

Jason A Hanko

USPTO Granted Patents = 15 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal4 out of 7 
 
Ferrokin Biosciences, Inc.
 patents
silverMedal4 out of 10 
 
Diatex, Inc.
 patents
bronzeMedal3 out of 43 
 
Cymabay Therapeutics, Inc.
 patents
4. 3 out of 549 
 
Celgene Corporation
 patents
5. 2 out of 41 
 
Metabolex, Inc.
 patents
6. 1 out of 6 
 
Cornerstone Therapeutics, Inc.
 patents
7. 1 out of 4,455 
 
Pfizer Corporation
 patents
8. 1 out of 25 
 
Noramco Gmbh
 patents
where one patent can have more than one assignee

Years Active: 2010-2017

Loading Chart...
15 patents (USPTO):
1. 9845285 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2017-12-19),
2. 9624271 - Romidepsin solid forms and uses thereof (2017-04-18),
3. 9518094 - Romidepsin solid forms and uses thereof (2016-12-13),
4. 9233914 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2016-01-12),
5. 8993797 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2015-03-31),
6. 8980825 - Romidepsin solid forms and uses thereof (2015-03-17),
7. 8846731 - Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents (2014-09-30),
8. 8829197 - Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents (2014-09-09),
9. 8710087 - Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents (2014-04-29),
10. 8536191 - Crystalline and amorphous forms of nalbuphine hydrochloride (2013-09-17),
11. 8507719 - Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto (2013-08-13),
12. 8203019 - Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto (2012-06-19),
13. 8063227 - Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents (2011-11-22),
14. 8003684 - Crystal form and pharmaceutical compositions of (+)-R-zileuton (2011-08-23),
15. 7692038 - Crystalline forms (2010-04-06),

Title: The Innovative Contributions of Jason A Hanko

Introduction

Jason A Hanko, an accomplished inventor based in West Lafayette, Indiana, has made significant contributions to the field of pharmaceuticals with a portfolio of 15 patents. His work primarily focuses on developing innovative compounds aimed at improving health outcomes for conditions such as Type 2 diabetes and hyperlipidemia.

Latest Patents

Hanko's latest patents showcase his dedication to advancements in medicinal chemistry. One such patent, titled "Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto," describes the development of crystalline and amorphous forms of (−)-halofenate. These innovative forms possess potential applications in pharmaceutical compositions, particularly for preventing and treating conditions associated with blood lipid deposition and Type 2 diabetes.

Another notable patent, "Romidepsin solid forms and uses thereof," focuses on the solid forms of a compound represented by a specific formula. This patent details various embodiments, including crystalline, solvate, and amorphous forms of the compound, all of which present unique opportunities for therapeutic applications.

Career Highlights

Throughout his career, Jason A Hanko has held key positions at various organizations, including Ferrokin Biosciences, Inc. and Diatex, Inc. His work at these companies has allowed him to further develop his innovative ideas and contribute to cutting-edge research in the pharmaceutical sector.

Collaborations

Hanko has collaborated with esteemed colleagues such as Eric J Hagen and Edward D Daugs. These collaborations have enriched his research endeavors and fostered a dynamic exchange of ideas, which is essential for driving innovation in complex fields like drug development.

Conclusion

Jason A Hanko stands out as a prominent inventor in the realm of pharmaceuticals, contributing valuable patents that aim to address critical health challenges. His continued work and collaborations promise further advancements that could significantly impact the medical community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…